Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,704.00
(
-0.39%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
113.88
(
6.85%
)
Bitcoin
70,197.37
(
-1.47%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 75014

Wednesday, 03/25/2009 10:31:03 PM

Wednesday, March 25, 2009 10:31:03 PM

Post# of 257257
MNTA – I don’t think the FDA’s non-action on Teva’s Citizen Petition for Copaxone was behind today’s stock move because the non-action letter is neutral for MNTA, not bullish. All the FDA has done is put off a decision on the CP until there’s an actual need for a decision to be made (i.e. after expiration of the automatic 30-month stay in early 2011).


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now